Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.36 |
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.35 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2873417 | 0.92 | NR1I2 (0.44) | MKNK1OPRM1NR1I2KDM4EHTT | |
| SCHEMBL102095 | 0.92 | NR1I2 (0.44) | MKNK1OPRM1NR1I2KDM4EHTT | |
| Hydrochloric Acid SCHEMBL2876957 | 0.91 | NR1I2 (0.43) | MKNK1OPRM1NR1I2KDM4EHTT | |
| Hydrochloric Acid SCHEMBL2876954 | 0.91 | NR1I2 (0.43) | MKNK1OPRM1NR1I2KDM4EHTT | |
| SCHEMBL12464670 | 0.89 | KDM4E (0.38) | OPRM1KDM4EHTTATM | |
| SCHEMBL2876653 | 0.89 | NR1I2 (0.46) | MKNK1OPRM1NR1I2KDM4EHTT | |
| Hydrochloric Acid SCHEMBL2871152 | 0.88 | NR1I2 (0.45) | MKNK1OPRM1NR1I2KDM4EHTT | |
| SCHEMBL12464253 | 0.87 | KDM4E (0.37) | KDM4EHTTATM | |
| SCHEMBL2876758 | 0.85 | NR1I2 (0.42) | MKNK1OPRM1NR1I2CACNA2D1 | |
| SCHEMBL2874205 | 0.84 | NR1I2 (0.43) | OPRM1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7985769-B2 | Compounds and methods for the treatment or prevention of Flavivirus infections | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-07-26 | — | — | US | disclosed |